|
|
 |
|
Viewing report
|
|
|
|
Merck & Co IMS Company Profile
IMS Health, March 2009, Pages: 186
This Company Profile gives you the authoritative insight into a company at a strategic and local level.
Each individual profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the relative strengths and weaknesses of a company’s business strategy.
- Critical analyses provided by an in-house expert team
- 90+ full in-depth company profiles covering all major pharmaceutical companies worldwide including private companies
- Includes some Generic, Biotechnology and Drug Delivery companies
- Includes sales data on products and therapies
- In depth product and R&D reviews, including clinical trial, lifecycle management, competition and analysts forecasts
- Mergers and acquisitions; licensing agreements
- Forecasts and comments from leading financial analysts
- Companies’ conferences, annual reports, press releases
- Comments from stockbrokers/analysts reports used throughout the profile and especially within the Strategy, Financial and Product sections.
Customers who bought this item also bought
Mylan: PharmaVitae Generics Profile
Serono: PharmaVitae Profile
Innovations in the Management of Diabetes: Next Generation Treatments and Market Dynamics
The North America Pharmaceuticals Sectors : A Company and Industry Analysis (November 2007)
Indian Bulk Drugs
Commercial Insight: Psoriasis - Intellectual property drives growth
The Cardiovascular Disorders Market Outlook to 2012
Osteoporosis - Novel Agents to Battle for Payer Acceptance
Commercial Insight: Parkinson's Disease - Japan and Europe to Drive Total Market Growth
The Europe Pharmaceuticals Sectors : A Company and Industry Analysis (January 2007)
Commercial Insight: Osteoarthritis and Rheumatoid Arthritis - New Growth In A Mature Market
Commercial Insight: Hormonal Contraceptives - Look Beyond Oral Contraception for a Competitive Edge
|
|
|
|
